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1. Introduction  
1.1 Definition 
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT 
lymphoma) is an extranodal lymphoma composed of morphologically heterogeneous small 
B-cells including marginal zone (centrocyte-like) cells, cells resembling monocytoid cells, 
small lymphocytes, and scattered immunoblasts and centroblast-like cells. There is plasma 
cell differentiation in a proportion of the cases. The infiltrate is in the marginal zone of 
reactive B-cell follicles and extends into the interfollicular region. In epithelial tissues, the 
neoplastic cells typically infiltrate the epithelium forming lymphoepithelial lesions. 
(Swerdlow et al., 2008) (Isaacson et al., 2004) 
1.2 Epidemiology 
MALT lymphoma accounts for 7% of all newly diagnosed lymphomas and is therefore one 
of the more common types of lymphoma (Swerdlow et al., 2008). Most cases occur in adults 
with a median age of 61 and a slight female preponderance (male:female ratio 1:1.2). (Anon, 
1997) There appears to be a higher incidence of gastric MALT lymphomas in north-east Italy 
(Doglioni et al., 1992) and a special subtype previously known as alpha heavy chain disease 
and now called immunoproliferative small intestinal disease (IPSID) occurs in the Middle 
East (Pinkel, 1998), the Cape region of South Africa (Price, 1990) and a variety of other 
tropical and subtropical locations. 
1.3 Etiology 
MALT lymphoma is a unique tumor in that it originates from acquired MALT associated 
with chronic inflammation or autoimmune responses, e.g. Helicobacter pylori (H. pylori)–
associated chronic gastritis, Hashimoto’s thyroiditis, and Sjögren’s syndrome (Swerdlow et 
al., 2008, Isaacson, 1999a). MALT lymphoma affects various organs, with the stomach being 
the most frequently involved (Swerdlow et al., 2008, Isaacson, 1999a, 1999b). Interestingly, 
the majority of gastric low-grade MALT lymphoma cases, those proven to be neoplastic by 
detection of monoclonal rearrangement in immunoglobulin heavy chain (IgH) genes, 
regress after eradication of H. pylori (Wotherspoon et al., 1993, Thiede et al., 2000). 
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1.4 Management 
MALT lymphomas have an indolent natural course and are slow to disseminate. 
Recurrences, that can occur after many years, may involve other extranodal sites and occur 
more often in patients with extragastric MALT lymphomas than in patients with primary 
gastric disease (Raderer et al., 2005). The tumors are sensitive to radiation therapy, and local 
treatment may be followed by prolonged disease-free intervals. Involvement of multiple 
extranodal sites and even BM involvement do not appear to confer a worse prognosis 
(Thieblemont et al., 2000). Protracted remissions may be included in H. pylori-associated 
gastric MALT lymphoma by antibiotic therapy for H. pylori (Neubauer et al., 1997, 
Wotherspoon et al., 1993). Cases with the t(14;18)(q21;q21) appear to be resistant to H. pylori 
eradication therapy (Liu et al., 2001). In IPSID, remissions have followed therapy with 
broad-spectrum antibiotics (Ben Ayed et al., 1989, Lecuit et al., 2004). Antibiotics have also 
been used to successfully treat selected other MALT lymphomas. Transformation to diffuse 
large B-cell lymphoma may occur. 
2. Regression of rectal MALT lymphoma after antibiotic treatments 
2.1 Introduction 
MALT lymphoma is less frequently seen in the rectum(Isaacson, 1999b, Morton et al., 1993, 
Koch et al., 2001), while the presence of MALT1 gene translocation in rectal MALT 
lymphoma has occasionally been reported (Motegi et al., 2000, Remstein et al., 2000, 
Yonezumi et al., 2001). In addition, a few reports have described the regression of rectal 
MALT lymphomas after antibiotic treatments that are generally found to be successful for 
gastric MALT lymphomas(Raderer et al., 2000, Matsumoto et al., 1997). 
In addition to H. pylori, various other infectious agents have been reported to be related to 
the development of MALT lymphoma, such as Borrelia burgdorferi in cutaneous(Roggero et 
al., 2000), Chlamydia psittaci in orbital(Ferreri et al., 2004), and Campylobacter jejuni in small 
intestinal lymphoma(Al-Saleem & Al-Mondhiry, 2005). However, few data are available on 
the pathogenesis of MALT lymphoma of organs other than the stomach. 
In this study, we examined 8 rectal MALT lymphomas to determine whether they regressed 
after antibiotic treatments. We report here our findings and also discuss the relationship 
between rectal MALT lymphomas and MALT1 gene genetic abnormalities (Niino et al., 2010). 
2.2 Materials and methods 
2.2.1 Rectal MALT lymphoma cases 
Formalin-fixed, paraffin-embedded tissues obtained between 2004 and 2007 from 8 cases 
of rectal MALT lymphoma treated with antibiotic treatments were retrieved from the 
pathology files at Kurume University School. The patients consisted of 2 men and 6 
women, ranging in age from 41 to 80 years (median, 66 years). Lymphomas constituting 
secondary involvement of the rectum were not included in the study. Clinical data for all 
cases were obtained from pathological reports and medical reports, and all cases were 
reviewed to confirm that the histological diagnosis conformed to the criteria of the World 
Health Organization Classification for Tumors of Hematopoietic and Lymphoid Tissues 
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(Swerdlow et al., 2008). Diagnosis of rectal MALT lymphomas was based on the following 
findings: centrocyte-like cells and/or monocytoid cell proliferation, especially at the 
outside of the mantle zone (marginal zone distribution); presence of plasmacytic 
differentiation and/or follicular colonization in some cases; and absence of CD5, CD10, 
and cyclin D1 overexpression. Lymphoepithelial lesions in rectal MALT lymphomas were 
not as obvious as those in gastric tumors (representative histologies are shown in Fig. 1.). 
All patients were Japanese. H. pylori infection was assessed by rapid- urease test or 
histological examination.  
 
 
Fig. 1. Hematoxylin and eosin staining show the histopathologic features of rectal mucosa-
associated lymphoid tissue (MALT) lymphoma. (A) Dense, diffuse atypical lymphocyte 
infiltration, mainly in submucosal layer. (B) MALT lymphoma cells showing small nuclei and 
abundant pale staining cytoplasm, resulting in a monocytoid appearance. (Niino et al., 2010) 
Because Inoue and Chiba reported a case without infection of H. pylori whose rectal MALT 
lymphoma regressed after administration of antibiotics(Inoue & Chiba, 1999), the patients 
were treated with antibiotic treatments. After informed consent had been obtained, 8 
patients underwent antibiotic treatments with a combination of antibiotics (clarithromycin 
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and amoxicillin), and follow-up endoscopic examinations including biopsies were 
performed. Tumor regression after antibiotic treatments was histologically evaluated. 
Complete regression (CR) was defined as the total disappearance of lymphoma and absence 
of histopathological evidence of lymphoma on endoscopic biopsy. No regression (NR) was 
diagnosed when no macroscopic or histologic changes were present. This study was carried 
out in accordance with the Helsinki Declaration as revised in 1989 and with the ethical 
guidelines of the participating centers and countries.  
2.2.2 Polymerase Chain Reaction (PCR) for the detection of IgH rearrangements 
DNA was extracted from 5-μm-thich sections of a paraffin block. Gene amplification of 
the IgH gene from the framework 2 part of the V segment to the J region by a seminested 
PCR was performed by using the consensus primers complementary to the framework  
2 portion of the VH region (FR2B) and the JH region (CFW1) from genomic DNA.  
The following primer sequences were used: FR2B, 5’-GTCCTGCAGGC(C/T)(C/T) 
CC-GG(A/G)AA(A/G)(A/G)GTCTGGAGTGG-3’; CFW1, 5’-ACCTGAGGAGACGGT-
GACCAGGGT-3’. The PCR conditions were as follows: after initial denaturation at 95°C 
for 10 min, 5 cycles (95°C for 30 s, 63°C for 30 s and 72°C for 30 s) followed by 45 cycles 
(95°C for 30 s, 60°C for 30 s and 72°C for 30 s) with a final extension at 72°C for 10 min. 
The size of the IgH rearrangement fragments was usually between 250 and 300 bp. 
2.2.3 MALT 1 gene translocation analysis 
All cases were analyzed using a MALT1 break-apart probe (Vysis, Downer’s Grove, IL, 
USA). Interphase fluorescence in situ hybridization (FISH) studies were performed on intact 
5-μm sections of formalin-fixed, paraffin-embedded material as previously described in 
detail(Wongchaowart et al., 2006). Briefly, slides were baked overnight at 60°C, 
deparaffinized, and subjected to proteinase K treatment. After washing, 10 mL of the probe 
solution was applied, and probe and target DNA were allowed to codenature at 73°C for 5 
minutes and to hybridize overnight at 3°C. Slides were counterstained with DAPI, and 
signals were visualized on an Axioskop photomicroscope (Zeiss, Oberkochen, Germany). 
For each probe 100-200 nuclei were scored. Nuclei were considered to be positive for a 
break-apart probe when a nucleus contained separate red and green signals at least three 
signal widths apart. Nuclei were scored as positive for +MALT1 when three or more signals 
were identified within one nucleus. Cutoffs for interpretation as a positive result were 
determined for each abnormality based on the analysis of six formalin-fixed, paraffin-
embedded sections of benign lymph nodes and tonsils used as control. Cutoff thresholds for 
each abnormality were established as the mean plus three standard deviations of the mean, 
so that positivity for MALT1 translocation, or +MALT1, was defined as >4% nuclei with a 
positive signal pattern. 
2.3 Results 
2.3.1 Clinical features of rectal MALT lymphoma 
Clinical characteristics of this study are shown in Table 1. The clinical records of all cases 
showed rectal origin. Four of eight patients (50%) were positive and one patient (13%) was 
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negative for H. pylori. The remaining patients were not evaluated for H. pylori. Five cases 
occurred as a single tumor, whereas the remaining three cases occurred as multiple tumors. 
Elevated lesions (polypoid or flat elevation) were formed in 7 cases, whereas circumferential 
lesion was formed in one case (Case 4). Representative endoscopic image before antibiotic 
treatment demonstrated multiple small polyps (Case 2) (Fig. 2.). The size of MALT 
lymphoma ranged from 5 to 100 mm. Seven cases were localized in the submucosa, whereas 
one case (Case 4) involved the subserosa. 
 
Fig. 2. Representative endoscopic image before antibiotic treatment (Case 2): Colonoscopy 
demonstrated multiple small polyps. (Niino et al., 2010) 
Case Age Sex Number Shape Size Depth LDH IL2R H.pylori 
no. (y) (mm) (IU/l) (U/ml) status 
1 67 F multiple polypoid 5-10 SM 178 888 positive 
2 68 F single flat elevation 25 SM 192 NA positive 
3 76 F single polypoid 10 SM NA NA NA 
4 65 M single circumferential 100 SS NA NA NA 
5 41 M multiple flat elevation 10 SM 215 530 negative 
6 80 F single polypoid 20 SM 160 369 positive 
7 54 F single polypoid 15 SM 156 NA positive 
8 46 F multiple polypoid 5-7 SM NA NA NA 
Abbreviations: LDH, lactate dehydrogenase; IL2R, interleukin 2 receptor; SM, submucosa;  
H.pylori, Helicobacter pyroli; SS, subserosa; NA, not available 
Table 1. Clinical characteristics of rectal MALT lymphoma. (Niino et al., 2010) 
2.3.2 Detection of IgH rearrangements and MALT1 gene translocation 
PCR for the detection of IgH rearrangement resulted in the identification of a monoclonal 
band in 7 cases (87.5%) (Table 2). 
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Results of interphase FISH studies are shown in Table 2 and Fig.3. All cases were 
successfully analyzed for MALT1 translocation by FISH. One case demonstrated MALT 1 
gene translocation (one fusion, one orange, and one green signal pattern), while another case 
demonstrated partial deletion of the MALT1 gene (one fusion and one green signal pattern). 
The others showed the normal pattern (two fusion signal patterns). That is, two cases (25%) 
showed genetic abnormality. 
 
Case PCR-IgH MALT1 FISH Response 
no. 
1 Monoclonal Negative CR 
2 Monoclonal Negative CR 
3 Monoclonal Negative CR 
4 Monoclonal Partial deletion NR 
5 Monoclonal Negative NR 
6 Polyclonal Negative CR 
7 Monoclonal Rearrangement NR 
8 Monoclonal Negative CR 
Abbreviations: PCR, polymerase chain reaction;  
IgH, immunoglobulin heavy chain; 
MALT, mucosa associated lymphoid tissue;  
FISH, fluorescence in situ hybridization; 
CR, complete regression; NR, no regression. 
Table 2. Results and clinical outcomes. (Niino et al., 2010) 
2.3.3 Therapeutic outcomes 
Therapeutic outcomes are shown in Table 2, 3. Eight patients who had undergone antibiotic 
treatments were subjected to follow-up colonoscopy after the treatment. Five patients 
(62.5%) achieved CR after a median follow-up from antibiotic treatments of 5 months (range, 
3 to 58 months). Three patients (37.5%) showed NR, among which received further 
treatment, including chemotherapy. These findings strongly indicate that these cases of 
rectal MALT lymphoma were responsive to antibiotic treatments. None of the patients who 
responded to antibiotic treatments harbored MALT1 gene genetic abnormality, but it was 
detected in two of the three patients who did not respond. The cases with MALT1 gene 
genetic abnormality thus tended to be resistant to antibiotic treatments. 
 
 Antibiotic treatments Antibiotic treatments  
  sensitive cases resistant cases Total 
Genetic abnormality (+) 0 2 2 
Genetic abnormality (-) 5 1 6 
Total 5 3 8 
Table 3. Relationship between antibiotic treatments sensitivity and MALT1 gene genetic 
abnormality. (Niino et al., 2010) 
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Fig. 3. Interphase fluorescence in situ hybridization (FISH) patterns in representative cases. 
(A) Normal pattern (two fusion signal patterns). (B) Partial deletion of MALT1 gene (one 
fusion and one green signal pattern; arrows). (Niino et al., 2010) 
2.4 Discussion 
Gastric MALT lymphoma is often associated with infection by H. pylori. Eradication of H. 
pylori has therefore been investigated as the first line of treatment for patients with MALT 
lymphoma of the stomach, and has been found to be highly effective for patients with 
localized low-grade disease. On the other hand, regression of rectal MALT lymphoma after 
antibiotic treatments has also been reported. Matsumoto et al. reported the first case with 
rectal MALT lymphoma that regressed after antibiotic treatment in 1997 (Matsumoto et al., 
1997). They also stated that the association of MALT lymphoma with H. pylori is not limited 
to the stomach, but involves other organs in which MALT is the predominant tissue for host 
defense. Inoue and Chiba reported a case without infection of H. pylori whose rectal MALT 
lymphoma regressed after administration of antibiotics(Inoue & Chiba, 1999). Nakase et al. 
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reported three H. pylori-negative cases of rectal MALT lymphoma which regressed after 
antibiotic treatments(Nakase et al., 2002). Regression of rectal MALT lymphoma after 
administration of quinolones has also been reported (Ferreri et al., 2005). These results 
suggest that some antigenic stimuli other than H. pylori may play a role in the pathogenesis 
of MALT lymphoma of the rectum, which is constantly exposed to intestinal bacteria and 
contents. However, for the time being this must remain an unproven hypothesis. 
Recently, the t(11;18) chromosomal translocation was identified as a specific chromosomal 
abnormality in some MALT lymphomas, and the API2-MALT1 fusion gene was found to be 
associated with this abnormality(Yonezumi et al., 2001). The MALT1 gene is cloned by 
18q21, while API2, an apoptosis inhibitor, is present in 11q21. Yonezumi et al. used RT-PCR 
to test a large series of MALT lymphomas for the presence of the AP12-MALT1 fusion gene 
and found that pulmonary MALT lymphomas showed the highest incidence of the AP12-
MALT1 gene (62.5%) while the occurrence rates of MALT lymphomas of the stomach, orbit 
and large intestine ranged from 10 to 20%(Yonezumi et al., 2001). Sakugawa et al. used RT-
PCR to examine 47 colorectal MALT lymphomas, including 27 primary rectal MALT 
lymphomas, for the API2-MALT1 fusion gene. API2-MALT1 fusion gene positivity was 
observed in 3 (11%) of 27 cases of rectal MALT lymphoma, and in 7 (15%) of 47 cases of 
colorectal MALT lymphoma(Sakugawa et al., 2003). In our study, the positive ratio for 
MALT1 gene genetic abnormality was 2 (25%) of 8 cases of rectal MALT lymphoma. In 
addition, we found that rectal MALT lymphomas with MALT1 gene genetic abnormality 
tend to be resistant for antibiotic treatments. 
3. Conclusion 
Ours is the first investigation of the regression of rectal MALT lymphoma after antibiotic 
treatments (Niino et al., 2010). Further follow-up will be needed to determine whether 
MALT lymphoma of the rectum regresses completely or is actually cured by antibiotic 
treatments. In addition, a large number of such cases needs to be analyzed to establish 
suitable standards for antibiotic treatments. 
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